EUVIMEDEUVIMED entdecken
Open Access

Dysregulated Protein s -Nitrosylation Promotes Nitrosative Stress and Disease Progression in Heart Failure With Preserved Ejection Fraction

Zhen Li iD, Kyle B LaPenna iD, Natalie D Gehred iD, Xiaoman Yu, W H Wilson Tang iD, Jake E Doiron iD, Huijing Xia, Jingshu Chen iD, Ian H Driver iD, Frank B Sachse iD, Naoto Muraoka iD, Antonia Katsouda iD und 15 weitere

Circulation Research · 2025

DOI: 10.1161/circresaha.124.326042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, 2025. Verfasst von Zhen Li und 26 weiteren Autor:innen. Beteiligte Einrichtung: School of Traditional Chinese Pharmacy (Z.L., X.Y.), China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Heart Failure, Nitrosative Stress, Stroke Volume. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIAAA NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Recent studies suggest aberrant elevation of iNOS (inducible NO synthase) expression and excessive protein s -nitrosylation promote the pathogenesis of heart failure with preserved ejection fraction (HFpEF). However, the interplay between NO bioavailability, enzymatic regulation of protein s -nitrosylation by transnitrosylase and denitrosylase, and HFpEF progression remains poorly defined. We investigated the molecular basis of nitrosative stress in HFpEF, focusing on alterations in NO signaling and regulation of protein s -nitrosylation. METHODS: Circulating nitrite (NO bioavailability) and nitrosothiols were quantified in patients with HFpEF. Parallel studies using rodent models of cardiometabolic HFpEF were performed to evaluate cardiac function, NO signaling, and total nitroso species during disease progression. Single-nucleus RNA sequencing and proteomic analysis were conducted to identify regulatory genes and cellular targets of pathological s -nitrosylation. RESULTS: In patients with HFpEF, circulating nitrosothiols were significantly elevated, indicating heightened nitrosative stress, whereas nitrite levels remained unchanged. In ZSF1 Obese (ob) rats, NO bioavailability declined with age, whereas total nitroso species progressively increased as HFpEF worsened. Transcriptomic analysis revealed marked upregulation of a transnitrosylase HBb (hemoglobin-β subunit), validated in both rat and human HFpEF hearts. Enzymatic assays demonstrated aberrant functions of Trx2 (thioredoxin 2) and GSNOR (S-nitrosoglutathione reductase) in ZSF1 Ob hearts. Cell-based experiments confirmed that altered expression or function of HBb, Trx2, and GSNOR resulted in elevated cellular RxNO. Additionally, similar dysregulation of s -nitrosylation dynamics was observed in the peripheral organs, such as the kidneys and liver, in HFpEF. CONCLUSIONS: These data demonstrate that nitrosative stress, evidenced by dysregulated protein s -nitrosylation occurs in the heart and peripheral organs in cardiometabolic HFpEF. Pathological alterations in NO bioavailability resulting from alterations in NOS expression or function alone do not account for this phenotype. Instead, pathological protein s -nitrosylation results in part from the imbalance between transnitrosylase and denitrosylase function. Restoration of physiological levels of protein s -nitrosylation and NO signaling may represent an effective therapeutic target for HFpEF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureNitrosative StressStroke VolumeAnimalsHumansMaleDisease ProgressionFemaleNitric OxideRatsAgedMiddle AgedDisease Models, AnimalAldehyde OxidoreductasesNitric Oxide Synthase Type IIRats, Zucker

Stichwörter der Autor:innen

beta-globinsheart failureheart failure, diastolichemoglobinsnitric oxidenitrosative stressprotein processing, post-translational

Substanzen

Nitric OxideAldehyde OxidoreductasesNitric Oxide Synthase Type II

Autor:innen und Institutionen

  • School of Traditional Chinese Pharmacy (Z.L., X.Y.), China Pharmaceutical University, Nanjing, China.
  • Department of Cardiac Surgery, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (Z.L., X.Y., T.T.G., D.J.L.).
  • Department of Pharmacology and Experimental Therapeutics, Cardiovascular Center of Excellence, Louisiana State University Health Sciences Center, New Orleans (K.B.L.P., J.E.D., H.X., A.G.H.).
  • Departments of Anesthesiology and Perioperative Medicine, Medicine and Physiology, Molecular Biology Institute, David Geffen School of Medicine at University of California, Los Angeles (N.D.G., T.G., T.M.V.).
  • Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute (W.H.W.T., A.Z.), Cleveland Clinic, OH.
  • Department of Cardiovascular and Metabolic Sciences, Center of Microbiome and Human Health (W.H.W.T., A.Z., J.W.), Cleveland Clinic, OH.

ORCID-Profile: Zhen Li, Kyle B LaPenna, Natalie D Gehred, W H Wilson Tang, Jake E Doiron, Jingshu Chen, Ian H Driver, Frank B Sachse, Naoto Muraoka, Antonia Katsouda, Paraskevas Zampas, Timothy D Allerton, Jennifer Wilcox, Tatiana Gromova, Andreas Papapetropoulos, Sanjiv J Shah, Martin B Jensen, Thomas E Sharp, Thomas M Vondriska, David J Lefer

Förderung

  • NHLBI NIH HHS
  • NIAAA NIH HHS
  • NIGMS NIH HHS
  • NCATS NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Li, Z., LaPenna, K. B., Gehred, N. D., Yu, X., Tang, W. H. W., Doiron, J. E., Xia, H., Chen, J., Driver, I. H., Sachse, F. B., Muraoka, N., Katsouda, A., Zampas, P., Haydel, A. G., Quiriarte, H., Allerton, T. D., Zagouras, A., Wilcox, J., Gromova, T., …, & Lefer, D. J. (2025). Dysregulated Protein s -Nitrosylation Promotes Nitrosative Stress and Disease Progression in Heart Failure With Preserved Ejection Fraction. Circulation Research. https://doi.org/10.1161/circresaha.124.326042

Vancouver

Li Z, LaPenna KB, Gehred ND, Yu X, Tang WHW, Doiron JE, et al. Dysregulated Protein s -Nitrosylation Promotes Nitrosative Stress and Disease Progression in Heart Failure With Preserved Ejection Fraction. Circulation Research. 2025. doi:10.1161/circresaha.124.326042

BibTeX
@article{Li2025,
  author = {Li, Zhen and LaPenna, Kyle B and Gehred, Natalie D and Yu, Xiaoman and Tang, W H Wilson and Doiron, Jake E and Xia, Huijing and Chen, Jingshu and Driver, Ian H and Sachse, Frank B and Muraoka, Naoto and Katsouda, Antonia and Zampas, Paraskevas and Haydel, Amelia G and Quiriarte, Heather and Allerton, Timothy D and Zagouras, Alexia and Wilcox, Jennifer and Gromova, Tatiana and Zheng, Yueqin and Papapetropoulos, Andreas and Shah, Sanjiv J and Goodchild, Traci T and Jensen, Martin B and Sharp, Thomas E and Vondriska, Thomas M and Lefer, David J},
  title = {Dysregulated Protein s -Nitrosylation Promotes Nitrosative Stress and Disease Progression in Heart Failure With Preserved Ejection Fraction},
  journal = {Circulation Research},
  year = {2025},
  doi = {10.1161/circresaha.124.326042}
}
Kostenlos starten →